{"title": "NVAX - I liked it at $300 I LOVE it at $180", "selftext": "Please read these two previous posts before you shit on my positions\n\n[1st Post](https://www.reddit.com/r/wallstreetbets/comments/lq3ksw/nvax_dont_miss_this_perfect_vaccine_play_headed/)\n\n[2nd Post](https://www.reddit.com/r/wallstreetbets/comments/luuige/nvax_part_ii_last_call_before_a_shit_ton_of/)\n\nFirst of all I want to say fucking GUH to my fellow NVAX brethren that have been riding this tendie rollercoaster with me. This is not for the faint of heart but I'm still positive on the outlook of this stock. Here are the negative events that have sent the stock down and my rebuttals to them:\n\n**1) US approval of JnJ vaccine and additional orders of MRNA and PFE** \\- The US at this point is pretty loaded with vaccine doses, we have enough as it is without NVAX to vaccinate all the US. This leads to the common misconception that NVAX is too late to the party and has missed out. However, the US is still going to purchase 110 million doses from NVAX no matter what once it is approved. The deal is already made. The US gov funded NVAX to get these doses they will not just refuse to buy them. Despite this I still insist the US market share DOES NOT MATTER. Here are a list of other deals NVAX has lined up\n\n* [SHIT TONS](https://ir.novavax.com/news-releases/news-release-details/novavax-announces-covid-19-vaccine-manufacturing-agreement-serum) of manufacturing deals leading to production of 2+ BILLION doses every year across the world\n* [1.1 BILLION dose deal](https://ir.novavax.com/news-releases/news-release-details/novavax-announces-memorandum-understanding-gavi-cumulative) with COVAX the majority of which will be vaccines from NVAX\n* [40 Million Doses](https://ir.novavax.com/news-releases/news-release-details/novavax-announces-expanded-collaboration-and-license-agreement) to South Korea\n* [6 Million Doses](https://ir.novavax.com/news-releases/news-release-details/novavax-and-government-switzerland-announce-agreement-principle) to the Swiss\n* [76 Million Doses + Manufacturing Deal](https://ir.novavax.com/news-releases/news-release-details/novavax-announces-memorandum-understanding-produce-covid-19) to our Poutine eating brethren\n* [51 Million Doses](https://ir.novavax.com/news-releases/news-release-details/novavax-finalizes-agreement-commonwealth-australia-51-million) to Australians\n* [10.7 Million Doses](https://ir.novavax.com/news-releases/news-release-details/novavax-announces-agreement-government-new-zealand-107-million) to the Kiwis\n* [60 Million Doses](https://ir.novavax.com/news-releases/news-release-details/novavax-and-uk-government-announce-collaboration-and-purchase) to the British\n\n**2) EU deal talks with NVAX fall apart citing manufacturing concerns -** OK this one sounds bad I admit. Could it be? NVAX can't actually secure enough of its raw materials to make vaccines for the EU? If they can't even do that how are we supposed to expect them to be able to make vaccines for the rest of the world? The truth is that NVAX was the one that refused to sign the deal with the EU. As demonstrated in [this article](https://www.thepavlovictoday.com/andrew-bridgen-mp-the-eu-and-ursula-von-der-leyen-set-out-to-teach-astrazeneca-a-lesson-but-only-shown-that-they-need-to-learn-one-themselves/) the EU has been an incredibly litigious vaccine customer and has made AZ's life hell. Hence why the EU has been [doing poorly](https://www.theguardian.com/world/2021/apr/06/eu-blames-astrazeneca-failure-for-sluggish-covid-vaccine-rollout) as far as vaccine rollout goes. Basically, NVAX has more than enough customers that are less troublesome than the EU willing to buy their product and NVAX only has so many doses readily available, why sell to the EU when you can sell to others?\n\n&#x200B;\n\n**3) Insider selling** \\- If you sell your positions when you see a headline about an insider selling stock you should really reconsider this investing hobby thing and go into buying beanie babies or whatever the fuck you feel more comfortable with because you'll never make money or be able to hug your kids with such fragile paper hands. Execs sell their stock all the time, they schedule selling months ahead of time or just want the money. In fact, NVAX execs were selling their stock at $125 just days before Phase 3 data came out that sent NVAX to $300+. It simply has not been indicative of catastrophic news. \n\n**4) General market pullback** \\- As many of you are aware the market has been extremely rocky in March and NVAX is not immune to this. In fact, being such a high beta stock it is more vulnerable. Biotech has been absolutely slammed by the market in March which makes this a PERFECT buying opportunity.\n\n&#x200B;\n\nNow onto the good stuff - two catalysts I expect this month:\n\n**1) UK Approval -** NVAX has completed its UK Phase 3 trial and the results look GREAT. At 96% efficacy it's the best performing vaccine reported to date. It already had submitted data to the UK as part of a rolling review and should get the approval by the [end of April](https://www.nasdaq.com/articles/novavax-covid-19-vaccine-could-be-approved-by-uk-in-april-evening-standard-says-2021-03-30). I cannot stress this enough, I do **not** think approval has been priced in. This would be the very first approval that NVAX has ever received and will finally validate it as a profitable company with a future. Canada, Australia, and NZ would very shortly follow in approvals if this passes in the UK.\n\n**2) US Phase 3 Results -** This will likely take investors by surprise! NVAX enrolled their phase 3 trial in record time which allowed them to get started much earlier than anticipated. Additionally, with 30,000 participants this trial is much larger than the UK trial and they will likely reach their endpoint targets in much less time than what the UK trial took. In fact, this US phase 3 trial [started crossover studies](https://www.marketwatch.com/story/novavax-to-expand-covid-19-vaccine-trials-to-children-teens-2021-04-05) which potentially indicates the interim endpoints have already been reached AND they are now expanding the trial to include children and teens. We were hoping for a long time that the FDA would use the UK phase 3 data but now we might not even have to wait for that.\n\n&#x200B;\n\nOther positive news/useful info:\n\n**1) This stock has gone through tremendous de-risking.** At $180 a share NVAX is almost down to the price it was before Phase 3 data came out. It can't fall much more, and at a market cap of 12.9 Bn it is grossly undervalued.\n\n**2) Other covid developements -** a) NVAX announced in their earnings call that SA variant trials would begin by the start of the summer and that these would be solely safety-based. If the original vaccine is approved for efficacy these would not have to demonstrate such rigorous efficacy data. b) NanoFlu+Covid or NanoFlu+Covid+RSV vaccine trials are supposed to start by the end of the year.\n\nPositions:\n\n$200c 5/21\n\n$200c 7/16\n\nPrice target = $400", "id": "mlielu", "created_utc": 1617733992.0, "score": 120, "upvote_ratio": 0.83, "num_comments": 78, "comments": [{"body": "Also the insider selling stuff is crap. Nearly everyone who sold shares excercised options shortly after to acquire the exact amount of shares they sold. They werent liquidating, they just dont want to invest more\n They want blow.", "score": 33, "replies": [{"body": "I know! I always btfd on insider selling news. Itâ€™s a non-issue.", "score": 5, "replies": [{"body": "Agree with you 10000%", "score": 1, "replies": []}]}, {"body": "And if you look at those report, most of them are actually executed by rule 10b5-1, which is a predetermined trading plan set up by the insider with the SEC, and is performed automatically.", "score": 2, "replies": []}, {"body": "Good day today!! I know youâ€™ve been riding this probably even longer than me. Letâ€™s keep this momentum going!!\n\nQuick question: Do you have any clarity on the UK approval process? From what I had heard they hadnâ€™t completed their â€œcmc packageâ€ so Iâ€™m not sure if theyâ€™ve actually even filed yet? Iâ€™m hoping for approval any day now and US phase 3 also any day now.", "score": 1, "replies": []}]}, {"body": "I've been holding long over a year. Bought a house and still holding. Novavax is derisked except for politics. And, the results are clearly best in class. Plenty of great catalysts will cause this to pop, but Sterilizing immunity is the key differentiator that will cause this to explode when US results released", "score": 12, "replies": []}, {"body": "Just had a look at the NVAX options... What's up with the insane prices? $180 strike for July $39.55...that is huge!", "score": 10, "replies": [{"body": "high IV", "score": 8, "replies": []}, {"body": "That tells you all you need to know about what Mr Market really thinks of this company despite the continued hammering down of the price. Options are tricky with this company because they stay tight lipped and often miss timing and targets. The crossover initiations is probably the best indicator of timing any of us longs have been granted since they got in the covid game. I would say 2-4 weeks before UK approval which is the biggest catalyst on deck that will send it.", "score": 11, "replies": [{"body": "I am confused as hell tbh but sod it worth a punt!", "score": 1, "replies": [{"body": "If no one thought it was going to rocket off the slew of imminent catalysts, options would be cheap as shit.", "score": 4, "replies": [{"body": "yeah. Premium for calls is very lucrative, too. I have 400 shares and im tempted, but I know it will rocket right past as soon as I do.", "score": 2, "replies": [{"body": "I ended up going for a different strategy and sold a couple of puts for decent premium... Best of both worlds", "score": 2, "replies": []}]}]}]}]}, {"body": "I dont option trade can you explain why huge?", "score": 1, "replies": [{"body": "The call options are expensive which means this is a volatile stock. The market thinks this bitch can pop or drop quickly.", "score": 5, "replies": [{"body": "Oh. Ya. As someone whos been holding since feb i absolutely have sea sickness", "score": 4, "replies": [{"body": "[deleted]", "score": 2, "replies": [{"body": "Holy crap did you really not sell when you were up 100x?", "score": 2, "replies": [{"body": "[deleted]", "score": 3, "replies": [{"body": "God speed man haha \n\nWith the exception of a single GME share, Iâ€™ve never held a stock beyond 100% gain let alone 10,000% lol", "score": 1, "replies": []}]}]}]}]}, {"body": "those spreads bro", "score": 1, "replies": []}]}]}]}, {"body": "Your subject line sounds like Seth from Boiler Room", "score": 7, "replies": []}, {"body": "EU deal - likely w more favorable terms once they receive UK approval - is still another major catalyst on the horizon. Thereâ€™s no way the EU fuckheads can remain so pompous once nvax is approved given the shitstorm their countries are in. \n\nSAEs for AZN & almost certainly J&J (both adenovirals) means they will not be factors in the future booster market. \n\nNvax will sell every dose they make in 2021 & will very likely be the annual booster leader post 2021. The market has not adequately priced that in \n\n~20 x Jan 22 180 & 340Cs", "score": 9, "replies": []}, {"body": "This stock is manipulated more than GME. It should already be over 350 with the agreements in place, efficacy and market cap. I feel like the whole world is sleeping on this one. The FUD is constant and the biggest bear thesis is â€œThEâ€™ve nEVeR bRouGhT anYtHInG tO MrrrrKEt!â€ bc of the failed RSV years ago. They didnâ€™t even fail, they just got jammed up by the FDA and were instructed to redo the trial and they couldnâ€™t afford to. Welcome to biotech, nerds. This shit is going to 1k per share when Nanoflu drops.", "score": 17, "replies": []}, {"body": "Dog i think fda is approving at same time or before uk. Fda cross over study starts april 20th and by my understand eua is given before crossover starts... like ca fucking ching bro. If im right this is gonnna catch the billion dollars sold short with their pants down.", "score": 8, "replies": [{"body": "This is more than likely tin foil hat theory, but Iâ€™m wondering if the accelerated date for vaccination availability in US by April 19th is because thereâ€™s gonna be an influx of NVAX vaccines when US EUA is awarded.", "score": 6, "replies": [{"body": "Its not that tin foil when you consider astras a no go and JJ just botched 15 million doses", "score": 3, "replies": [{"body": "I dont think astras is no go long term.", "score": 1, "replies": [{"body": "Fauci said it is for the usa because we have enough between pfizer jj mrna and novavax. His exact words last Friday", "score": 5, "replies": []}, {"body": "Nah keep that shit on Europe.  We don't want it.", "score": 2, "replies": [{"body": "Yeah blood clots? No thanks. Iâ€™d rather stick a crack needle in me than AstraZenecaâ€™s BS vax", "score": 1, "replies": []}]}]}]}]}]}, {"body": "https://bethesdamagazine.com/bethesda-beat/development/novavax-plan-outlines-expansion-of-gaithersburg-corporate-campus/\n\nTldr novavax applying for code approval to develop 610 thousand square foot campus in addition to their existent 70 thousand.", "score": 7, "replies": [{"body": "Hiring like crazy too for the long term it seems", "score": 1, "replies": []}]}, {"body": ".... That horrible feeling when you knew that it could've been a win at $12 dollars. But you did nothing.", "score": 3, "replies": []}, {"body": "Still holding a few shares, but if it drops a little more, calls might be very tasty", "score": 3, "replies": []}, {"body": "I'm just trying starting to try and get my first option trade brain wrinkles so I'm just studying and paper trading options right now but I think these are the highest premiums I have ever seen when it comes to buying options.", "score": 3, "replies": [{"body": "Yeah theyâ€™re pretty damn high, not quite GME levels but def high", "score": 1, "replies": []}]}, {"body": "Bought 1 share, I'm outta money now :D", "score": 3, "replies": []}, {"body": "I'd buy if I wasn't in Tesla and GameStop", "score": 2, "replies": []}, {"body": "IV is pretty high for options..some credit spreads or CSP could do well. Or just buy the shares straight up.", "score": 2, "replies": []}, {"body": "Long since Nov 2019. $400 is a good start.", "score": 2, "replies": []}, {"body": "Iâ€™ve been wrecked trying to buy this Dip. Do you think the pop to $330 was mainly short driven? \n\nI am starting to think the weakness on price is from the longitudinal studies of Pfizer and Moderna coming out and showing efficacy at 6months. Basically if vaccines are that effective the overall market shrinks. \n\nAlso keep in mind moderna valuation is based on their anti cancer pipeline. So Iâ€™m not sure we can expect much more than 20B market cap for NVAX. Maybe somewhere near $250-$300 range given market size/share uncertainty", "score": 2, "replies": [{"body": "I believe youâ€™re forgetting about p3 trials for Nanoflu and RSV that were paused to pivot to covid. Once covid approval happens, itâ€™s only a matter of time before flu and RSV vaccines are approved. Then thereâ€™s the whole idea behind multivalent shots to protect against several variants of covid all at once. Then thereâ€™s the thought of using all three in coordination. \n\nI agree with MRNAâ€™s mRNA platformâ€™s has added value when considering itâ€™s potential applicability to cancer immunotherapies.", "score": 2, "replies": [{"body": "Well thereâ€™s also innovation form Moderna. They are trialing multitalented vaccines but only 2 strains. From what I understand NVAX could offer up to 5 strains. Moderna is also working on room temperature stability. \n\nItâ€™s still a race. \n\nI think itâ€™s moving up based on the news that COVAX needs 2B doses. And sees new waves in India+Brazil. America may get another wave as well. \n\nHoping for approval and the some kind of revenue guidance from NVAX.", "score": 1, "replies": []}]}]}, {"body": "Ok. I'm holding 200 long at $176. Thinking about buying some calls if it stays down (already burned $3k in NVAX calls last month). What kind of call/timing are you liking? ðŸš€ðŸš€", "score": 2, "replies": [{"body": "I am in deep with 5/21 $200c. Itâ€™s a nice round number so it has more volume and itâ€™s decently far as to not kill you with theta. Plan is to sell these after these upcoming catalysts (UK approval and US ph3 data) and then buy into longer term share positions.\n\nI also like the July expiration", "score": 3, "replies": []}]}, {"body": ">First of all I want to say fucking GUH to my fellow NVAX brethren that have been riding this tendie rollercoaster with me.\n\nYeah, it's been tough to be a NVAX bull lately. Enjoy seeing the updates though. I'm selling everything (50ish shares and some credit spreads) if it hits $280-300 anytime soon, hopefully before end of year. Can't handle the volatility tbh.\n\nThey really get no press and take their time for everything they do... Knowing this, US P3 results will probably take longer than anticipated. It seems they also like to release on Thursdays too, so maybe next Thursday if they're actually ready?", "score": 2, "replies": [{"body": "Yeah Iâ€™m def long term bullish still but I think if we pop on approval news Iâ€™ll sell all my calls and buy back in with shares later when they take a breather.", "score": 2, "replies": []}]}, {"body": "Nice pop today, hopefully itâ€™s gets momentum moving in the positive direction.", "score": 2, "replies": []}, {"body": "You will love it more at 50", "score": -6, "replies": [{"body": "Short it than pussy", "score": 5, "replies": [{"body": "Position or ban!", "score": 3, "replies": []}, {"body": "Just wanted to come back to remind you that itâ€™s almost 50. Show some love", "score": 1, "replies": []}]}, {"body": "Fuckin ban this clown", "score": 2, "replies": [{"body": "Sorry for your loss", "score": -3, "replies": [{"body": "Make him walk the fucking short plank", "score": 2, "replies": []}]}]}]}, {"body": "[deleted]", "score": 0, "replies": [{"body": "Itâ€™s a double blind study. Could have gotten a placebo", "score": 4, "replies": [{"body": "[deleted]", "score": 0, "replies": [{"body": "Welllllllll thatâ€™s shady as fuck and more worrisome than them just getting sick after vaxxed.", "score": 1, "replies": []}]}]}, {"body": "If you're even telling the truth, it sounds more like that person was lying to excuse their bad behavior", "score": 1, "replies": []}]}, {"body": "Come on $NVAX!\n\n$NVAX is just riding the market volatility with the rest of the market, that coupled with the good/bad publicity recently as it took a hit for apparent production issues its still in a good position to pick itself up and ride to a comfortable $210-$220 as it progresses through its trials and whatever issues they may or may not be having with raw materials.\n\n*I don't know what im talking about I just read things on the internet and try to sound clever.*", "score": 1, "replies": []}, {"body": "I don't even have the margin for bull call spreads but I might throw some more money in so I can afford this play.", "score": 1, "replies": []}, {"body": "~~I went for an affordable longshot call spread 240/270 July as that's only .62 a piece with a 2,900% upside.~~\n\nGood luck to us both.\n\n*WRONG THREAD BUT GOOD LUCK ANYWAY*", "score": 1, "replies": [{"body": "Thatâ€™s solid! Best of luck", "score": 1, "replies": []}]}]}
